Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRTX
日付受信時刻ニュースソース見出しコード企業名
2022/10/2805 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/2805 : 01Business WireVertex Reports Third Quarter 2022 Financial ResultsNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/2705 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/2105 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/1405 : 05Business WireVertex to Announce Third Quarter 2022 Financial Results on October 27NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/1121 : 00Business WireVertex Advances Program Targeting Alpha-1 Antitrypsin DeficiencyNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/10/0105 : 32TipRanksVRTX vs. SRPT: Which Biotech Stock is Better?NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/2720 : 29Business WireVertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/2205 : 11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/0822 : 00Business WireVertex Appoints Jonathan Biller as Chief Legal OfficerNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/0610 : 45TipRanksRBC Capital Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/0303 : 19Dow Jones NewsVertex Pharmaceuticals Gets FDA Approval for Cystic Fibrosis Drug Orkambi in ChildrenNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/09/0302 : 15Business WireVertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 monthsNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/3121 : 13Business WireVertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1806 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1806 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1806 : 36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1605 : 05GlobeNewswire Inc.Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial ResultsNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1305 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1305 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1218 : 07TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Natera (NTRA) and Arrowhead Pharmaceuticals (ARWR)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1211 : 20TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Acutus Medical (AFIB)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1105 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1105 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1105 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1105 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/1105 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/0620 : 26TipRanksMaxim Group Believes Vertex Pharmaceuticals (VRTX) Still Has Room to GrowNASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/0605 : 12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRTXVertex Pharmaceuticals Inc
2022/08/0605 : 09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRTXVertex Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRTX

最近閲覧した銘柄

Delayed Upgrade Clock